iScience (May 2023)

Dichotomous ovarian cancer-initiating potential of Pax8+ cells revealed by a mouse genetic mosaic model

  • Jianhao Zeng,
  • Astrid Catalina Alvarez-Yela,
  • Eli Casarez,
  • Ying Jiang,
  • Lixin Wang,
  • Brianna E. Kelly,
  • Taylor Jenkins,
  • Eugene Ke,
  • Kristen A. Atkins,
  • Kevin A. Janes,
  • Jill K. Slack-Davis,
  • Hui Zong

Journal volume & issue
Vol. 26, no. 5
p. 106742

Abstract

Read online

Summary: Different cellular compartments within a tissue present distinct cancer-initiating capacities. Current approaches to dissect such heterogeneity require cell-type-specific genetic tools based on a well-understood lineage hierarchy, which are lacking for many tissues. Here, we circumvented this hurdle and revealed the dichotomous capacity of fallopian tube Pax8+ cells in initiating ovarian cancer, utilizing a mouse genetic system that stochastically generates rare GFP-labeled mutant cells. Through clonal analysis and spatial profiling, we determined that only clones founded by rare, stem/progenitor-like Pax8+ cells can expand on acquiring oncogenic mutations whereas vast majority of clones stall immediately. Furthermore, expanded mutant clones undergo further attrition: many turn quiescent shortly after the initial expansion, whereas others sustain proliferation and manifest a bias toward Pax8+ fate, underlying early pathogenesis. Our study showcases the power of genetic mosaic system-based clonal analysis for revealing cellular heterogeneity of cancer-initiating capacity in tissues with limited prior knowledge of lineage hierarchy.

Keywords